期刊文献+

SRY-box 17基因在食管鳞状细胞癌中异常甲基化及表达的研究 被引量:1

Hypermethylation and aberrant expression of SRY-box17 gene in esophageal squamous cell cancer
原文传递
导出
摘要 目的:检测食管磷癌(esophageal squamous cell cancer,ESCC)细胞株及组织标本中Wnt通路相关因子SRY-box17基因的甲基化状态及表达情况,探讨其与食管鳞癌发生的相关性。方法:分别采用甲基化特异性-PCR(methylation specific-PCR,MSP)和RT-PCR的方法检测食管癌细胞株TE1、TE13及109例食管鳞癌及相应癌旁非肿瘤组织中SRY-box17基因的甲基化状态及mRNA表达情况,并分析其与Wnt通路中心因子β-catenin蛋白表达的关系。结果:在食管癌细胞株TE1和TE13中,SRY-box17基因mRNA均呈阴性或弱阳性表达,用甲基化抑制剂5-氮-2’-脱氧胞苷(5-aza-2’-deoxycytidine,5-Aza-dC)处理后,其mRNA全部恢复阳性表达;MSP检测结果显示,在食管癌细胞株中SRY-box17基因均呈高甲基化状态;在食管癌组织标本中,SRY-box17基因的甲基率为89.0%(97/109),明显高于癌旁组织的53.2%(58/109)(P<0.01);癌组织中SRY-box17基因的甲基化率在Ⅲ和Ⅳ期肿瘤患者中明显高于Ⅰ和Ⅱ期患者(P<0.05),而该基因的甲基化率与肿瘤患者的组织学分级无相关性;在癌组织中该SRY-box17mRNA的阳性表达率为28.4%(31/109),明显低于癌旁组织(P<0.01)。其mRNA表达的缺失率及通路中心因子β-catenin蛋白的异质表达率均与该基因的甲基化状态有相关性(P<0.05)。结论:食管鳞癌组织及细胞株中SRY-box17基因均呈高甲基化状态,该基因的高甲基化可能是引起mRNA表达下调的重要机制之一,并可能通过Wnt/β-catenin信号转导通路的激活在食管癌的发生、发展中具有重要作用;对该基因的甲基化检测可能对食管癌的预后判断有一定的临床指导意义。 Objective: To investigate the methylation status of SRY-box17 gene in Wnt signaling pathway in esophageal squamous cell carcinoma (ESCC) cell lines and ESCC tissues, and to explore the association between SRY-box17 gene and the pathogenesis of ESCC. Methods: The methylation of SRY-box17 gene and its mRNA expression in ESCC cell lines TE1 and TE13 as well as ESCC tissues and their adjacent tissues from 109 patients were detected by methylation specific-PCR (MSP) and RT-PCR, respectively. The association of SRY-box17 gene with β-catenin in Wnt signaling pathway was analyzed. Results: The expression of SRY-box17 mRNA was undetected or at extremely low level in ESCC cell lines TE1 and TE13. The expression level of SRY-box17 mRNA was obviously increased after treatment with a demethylation agent 5-aza-2’-deoxycytidine (5-Aza-dC). The result of MSP indicated that the SRY-box17 gene exerted a hypermethylation status in ESCC cell lines TE1 and TE13. The methylation rate of SRY-box17 gene was 89.0% (97/109) in the ESCC tissues, which was significantly higher than that in the adjacent tissues [53.2% (58/109); P〈0.01]. The methylation rates of SRY-box17 gene for clinical stage Ⅲ-Ⅳ was significantly higher than that for clinical stage Ⅰ-Ⅱ (P〈0.05), but the methylation rate was not associated with the histologic grade (P〈0.05). Furthermore, the positive rate of SRY-box17 mRNA expression [28.4% (31/109)] in the ESCC tissues was significantly lower than that in the adjacent tissues. The hypermethylation status of SRY-box17 gene was associated with the loss of SRY-box17 mRNA expression and the ectopic expression of β-catenin (P〈0.05). Conclusion: The hypermethylation of SRY-box17 gene is a frequent event in ESCC cell lines and the ESCC tissues, and it may play an important role in the downregulation of SRY-box17 mRNA expression and the pathogenesis and development of ESCC through the activation of Wnt/β-catenin signaling pathway. Analysis of methylation status of S
出处 《肿瘤》 CAS CSCD 北大核心 2012年第4期269-274,共6页 Tumor
基金 河北省医学科学研究重点课题计划资助项目(编号:20090466)
关键词 食管肿瘤 DNA甲基化 SRY-box17基因 Esophageal neoplasms DNA methylation SRY-box17 gene
  • 相关文献

参考文献13

  • 1YAMAMOTO H.Regulation of Wnt signaling pathway and its relationship with tumorigenesis[J].Seikagaku,2008,80(12):1079-1093. 被引量:1
  • 2GUO Y,GUO W,CHEN Z,et al.Hypermethylation and aberrant expression of Wnt-antagonist family genes in gastric cardia adenocarcinoma[J].Neoplasma,2011,58(2):110-117. 被引量:1
  • 3郭艳丽,郭炜,邝钢,杨植彬,董稚明.食管鳞癌及贲门腺癌中分泌型卷曲相关蛋白4基因启动子区甲基化状态的联合检测[J].肿瘤,2010,30(7):603-607. 被引量:3
  • 4JAY D,KORMISH,DE’BORA SINNER,et al.Interactions between SOX factors and wnt/β-catenin signaling in development and disease[J].Developmental Dynamics,2010,239(1):56–68. 被引量:1
  • 5TAMASHIRO D A,ALAR CON V B,MARIKAWA Y.Ectopic expression of mouse Sry interferes with Wnt/beta-catenin signaling in mouse embryonal carcinoma cell lines[J].Biochim Biophys Acta,2008,1780(12):1395-1402. 被引量:1
  • 6HERMAN J G,GRAFF J R,MY?H?NEN S,et al.Methylation-specific PCR:a novel PCR assay for methylation status of CpG islands[J].Proc Natl Acad Sci U S A,1996,93:9821–9826. 被引量:1
  • 7FOSTER J W,DOMINGUEZ STEGLICH M A,GUIOLI S,et al.Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene[J].Nature,1994,372(6506):525-530. 被引量:1
  • 8HAWKINS J R.Sex determination[J].Hum Mol Genet,1994,3:1463-1467. 被引量:1
  • 9NELSON W J,NUSSE R.Convergence of Wnt,beta-catenin,and cadherin pathways[J].Science,2004,303(5663):1483-1487. 被引量:1
  • 10DE BONT J M,KROS J M,PASSIER M M,et al.Differential expression and prognostic significance of Sox genes in pediatric medulloblastoma and ependymoma identified by micro array analysis[J].Neuro Oncol,2008,10(5):648-660. 被引量:1

二级参考文献10

  • 1YAMAMOTO H.Regulation of Wnt signaling pathway and its relationship with tumorigenesis[J].Seikagaku,2008,80(12):1079-1093. 被引量:1
  • 2CHIM C S,PANG R,LIANG R.Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia[J].Clin Pathol,2008,61(11):1214-1219. 被引量:1
  • 3SUZUKI H,TOYOTA M,CARRAWAY H,et al.Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer[J].Br J Cancer,2008,98(6):1147-1156. 被引量:1
  • 4LIN Y W,CHUNG M T,LAI H C,et al.Methylation analysis of SFRP genes family in cervical adenocarcinoma[J].Cancer Res Clin Oncol,2009,135(12):1665-1674. 被引量:1
  • 5BIRD A.Molecular biology.Methylation talk between histones and DNA[J].Science,2001,294(5549):2113-2115. 被引量:1
  • 6KANSARA M,TSANG M,KODJABACHIAN L,et al.Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma,and targeted disruption accelerates osteosarcomagenesis in mice[J].J Clin Invest,2009,119(4):758-760. 被引量:1
  • 7CHUNG M T,SYTWU H K,YAN M D,et al.Promoter methylation of SFRPs gene family in cervical cancer[J].Gynecol Oncol,2009,112(2):301-306. 被引量:1
  • 8陈志峰,侯浚,贺宇彤,王士杰.食管胃交界腺癌—肿瘤登记面临的新课题[J].中国肿瘤临床,2007,34(24):1381-1382. 被引量:26
  • 9齐健,朱尤庆,罗峻,陶文惠,张晶梅.结直肠肿瘤中sFRP基因的甲基化及表达调控[J].中华肿瘤杂志,2007,29(11):842-845. 被引量:13
  • 10杜彦艳,刘鑫,单保恩.Wnt/β-catenin信号转导通路与肿瘤关系的研究进展[J].肿瘤,2009,29(8):803-806. 被引量:26

共引文献2

同被引文献12

  • 1ZELLER C, BROWN R. Therapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer[J]. Ther Adv Med Oncol, 2010, 2(5): 319-329. 被引量:1
  • 2SWISHER E M, GONZALEZ R M, TANIGUCHI T, et al. Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas[J]. Mol Cancer, 2009, 8: 48. 被引量:1
  • 3LIM S L, SMITH P, SYED N, et al. Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer[J]. BrJ Cancer, 2008,98(8): 1452-1456. 被引量:1
  • 4WANG Z, LI M, LU S, et al. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway[J]. Cancer Bio! Ther, 2006, 5(3): 256-260. 被引量:1
  • 5CHIAM K, CENTENERA M M, BUTLER LM, et al. GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells[J]. PIoS One, 2011, 6(9): e25634. 被引量:1
  • 6TANIGUCHI T, TISCHKOWlTZ M, AMEZIANE N, et al. Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors[J]. Nat Med, 2003, 9(5): 568-574. 被引量:1
  • 7BENDER C M, PAO M M, JONES P A. Inhibition of DNA methylation by 5-Aza-2'-deoxycytidine suppresses the growth of human tumor cell lines[J]. Cancer Res, 1998, 58(1 ): 95-101. 被引量:1
  • 8CHEN H, HARDY T M, TOLLEFSBOL T O. Epigenomics of ovarian cancer and its chemoprevention[J]. Front Genet, 2011,2: 67. 被引量:1
  • 9SHI J, ZHANG G, YAO D, et al. Prognostic significance of aberrant gene methylation in gastric cancer[J]. Am J Cancer Res, 2012, 2(1): 116-129. 被引量:1
  • 10FABIANI E, LEONE G, GIACHELIA M, et al. Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent myeloid leukemia[J]. 51 (12): 2275-2284. methylation target in acute Leuk Lyrnphorna, 2010,. 被引量:1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部